Preparing to monitor muscle inflammation in Duchenne muscular dystrophy
Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy
This study is looking for better ways to track muscle inflammation in people with Duchenne muscular dystrophy (DMD) so that future treatments can be tested more effectively.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of Ny,binghamton NIH-funded |
| Lab location | 1 site (Binghamton, United States) |
| Project ID | NIH-10891745 on NIH RePORTER |
What this research studies
This research focuses on developing methods to effectively monitor muscle inflammation in patients with Duchenne muscular dystrophy (DMD). It aims to establish clinical trial readiness by identifying reliable biomarkers and assessment techniques that can be used in future studies. The approach involves analyzing muscle tissue and blood samples to understand the inflammatory processes associated with DMD. By enhancing the ability to track disease progression and treatment response, this research seeks to improve the design of clinical trials for new therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy, particularly those experiencing muscle inflammation.
Not a fit: Patients with other forms of muscular dystrophy or those without muscle inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring and treatment strategies for patients with Duchenne muscular dystrophy.
How similar studies have performed: Other research has shown promise in using biomarkers to monitor muscle diseases, but this specific approach to DMD is relatively novel.
Where this research is happening
Binghamton, United States
- State University of Ny,binghamton — Binghamton, United States (Active)
Researchers
- Principal investigator: Hoffman, Eric P. — State University of Ny,binghamton
- Study coordinator: Hoffman, Eric P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.